Conclusions
This economic evaluation has shown MSS+SAU accrue more benefits than SAU, but these increased benefits come at a greater cost. The main drivers of these increased costs were the costs of delivering the MSS course. Whether these benefits are considered to be worth the additional cost depends on the cost-effectiveness threshold adopted—this is not established for the university sector. Compared with the NICE threshold for the NHS, MSS+SAU would be considered highly cost-effective compared with SAU.